Recent pharmaceutical excessive pricing cases in context
Baker McKenzie global antitrust head Fiona Carlin, assisted by Washington, DC, partner Creighton Macy and Johannesburg partner Nick Altini, examines international trends in excessive pricing enforcement against high generic drug prices - and considers whether the recent spike in activity could be a sign that enforcers are expanding the definition of the infringement.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.